AMG National Trust Bank Sells 37 Shares of Intuitive Surgical, Inc. (NASDAQ:ISRG)

AMG National Trust Bank lessened its holdings in Intuitive Surgical, Inc. (NASDAQ:ISRG) by 1.6% during the third quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The fund owned 2,237 shares of the medical equipment provider’s stock after selling 37 shares during the period. AMG National Trust Bank’s holdings in Intuitive Surgical were worth $1,099,000 at the end of the most recent reporting period.

Several other institutional investors also recently modified their holdings of the business. Creekmur Asset Management LLC raised its position in Intuitive Surgical by 200.0% in the first quarter. Creekmur Asset Management LLC now owns 63 shares of the medical equipment provider’s stock worth $25,000 after acquiring an additional 42 shares during the period. Ridgewood Investments LLC purchased a new stake in shares of Intuitive Surgical during the 2nd quarter worth approximately $26,000. Godsey & Gibb Inc. raised its holdings in shares of Intuitive Surgical by 140.0% in the 3rd quarter. Godsey & Gibb Inc. now owns 60 shares of the medical equipment provider’s stock worth $29,000 after purchasing an additional 35 shares during the period. LRI Investments LLC purchased a new position in Intuitive Surgical in the first quarter valued at approximately $30,000. Finally, LGT Financial Advisors LLC grew its holdings in Intuitive Surgical by 415.4% during the second quarter. LGT Financial Advisors LLC now owns 67 shares of the medical equipment provider’s stock valued at $30,000 after purchasing an additional 54 shares during the period. 83.64% of the stock is owned by institutional investors.

Intuitive Surgical Trading Up 1.4 %

Shares of NASDAQ ISRG opened at $538.82 on Wednesday. The business has a 50-day moving average of $501.42 and a 200-day moving average of $460.69. The firm has a market capitalization of $191.92 billion, a price-to-earnings ratio of 86.63, a PEG ratio of 5.19 and a beta of 1.39. Intuitive Surgical, Inc. has a 12 month low of $304.50 and a 12 month high of $544.38.

Intuitive Surgical (NASDAQ:ISRG) last issued its quarterly earnings results on Thursday, October 17th. The medical equipment provider reported $1.56 EPS for the quarter, topping analysts’ consensus estimates of $1.24 by $0.32. Intuitive Surgical had a net margin of 28.51% and a return on equity of 13.41%. The firm had revenue of $2.04 billion for the quarter, compared to analyst estimates of $2.01 billion. On average, analysts predict that Intuitive Surgical, Inc. will post 5.45 earnings per share for the current year.

Insider Buying and Selling at Intuitive Surgical

In other Intuitive Surgical news, SVP Henry L. Charlton sold 40,243 shares of the stock in a transaction that occurred on Friday, August 23rd. The shares were sold at an average price of $486.84, for a total transaction of $19,591,902.12. Following the transaction, the senior vice president now directly owns 3,001 shares in the company, valued at $1,461,006.84. This trade represents a 93.06 % decrease in their ownership of the stock. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available at this hyperlink. Also, EVP Robert Desantis sold 396 shares of Intuitive Surgical stock in a transaction that occurred on Monday, August 26th. The stock was sold at an average price of $486.88, for a total transaction of $192,804.48. Following the transaction, the executive vice president now directly owns 5,506 shares in the company, valued at $2,680,761.28. This trade represents a 6.71 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders have sold 91,178 shares of company stock worth $45,897,071 over the last 90 days. Corporate insiders own 0.80% of the company’s stock.

Wall Street Analyst Weigh In

ISRG has been the topic of a number of recent research reports. Redburn Atlantic raised Intuitive Surgical from a “neutral” rating to a “buy” rating and upped their price target for the company from $380.00 to $510.00 in a research report on Friday, August 2nd. Wells Fargo & Company increased their target price on shares of Intuitive Surgical from $466.00 to $549.00 and gave the stock an “overweight” rating in a research report on Friday, October 18th. Mizuho boosted their price target on shares of Intuitive Surgical from $440.00 to $500.00 in a research report on Thursday, October 17th. The Goldman Sachs Group set a $604.00 price objective on shares of Intuitive Surgical in a report on Friday, October 18th. Finally, Robert W. Baird boosted their target price on shares of Intuitive Surgical from $503.00 to $565.00 and gave the company an “outperform” rating in a report on Thursday, October 17th. One equities research analyst has rated the stock with a sell rating, five have assigned a hold rating and fourteen have issued a buy rating to the company’s stock. According to MarketBeat.com, Intuitive Surgical currently has a consensus rating of “Moderate Buy” and a consensus target price of $524.61.

About Intuitive Surgical

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.